We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.98B
AUM Growth
+$132M
Cap. Flow
+$20.2M
Cap. Flow %
0.34%
Top 10 Hldgs %
41.51%
Holding
666
New
23
Increased
324
Reduced
223
Closed
42

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$142M
2
ASML icon
ASML
ASML
+$117M
3
TSEM icon
Tower Semiconductor
TSEM
+$112M
4
LRCX icon
Lam Research
LRCX
+$88M
5
MU icon
Micron Technology
MU
+$53.9M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$81.3M
2
LITE icon
Lumentum
LITE
+$72.3M
3
PM icon
Philip Morris
PM
+$40M
4
MSFT icon
Microsoft
MSFT
+$28.5M
5
META icon
Meta Platforms (Facebook)
META
+$27.2M

Sector Composition

Rank Sector Weight
1 Technology 54.47%
2 Communication Services 12.44%
3 Consumer Discretionary 11.77%
4 Consumer Staples 6.03%
5 Healthcare 5.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MAZE
451
Maze Therapeutics
MAZE
$1.62B
$32.2K ﹤0.01%
1,080
+136
+14% +$6K
PK icon
452
Park Hotels & Resorts
PK
$3.03B
$31.8K ﹤0.01%
3,022
-307
-9% -$3.39K
IOVA icon
453
Iovance Biotherapeutics
IOVA
$2.45B
$31.3K ﹤0.01%
8,915
+1,085
+14% +$3.47K
PGEN icon
454
Precigen
PGEN
$1.96B
$30.6K ﹤0.01%
7,914
+962
+14% +$3.95K
MBX
455
MBX Biosciences
MBX
$2.87B
$30.1K ﹤0.01%
1,009
+127
+14% +$4.32K
NVAX icon
456
Novavax
NVAX
$1.33B
$29.6K ﹤0.01%
3,633
+440
+14% +$3.99K
IMCR icon
457
Immunocore
IMCR
$1.75B
$29.5K ﹤0.01%
980
+123
+14% +$3.98K
HROW icon
458
Harrow
HROW
$1.63B
$29.3K ﹤0.01%
832
+106
+15% +$4.66K
DRH icon
459
Diamondrock Hospitality Co
DRH
$2.65B
$29K ﹤0.01%
3,099
-297
-9% -$2.83K
ATAI icon
460
AtaiBeckley Inc
ATAI
$2.64B
$28.8K ﹤0.01%
8,125
+988
+14% +$3.72K
GNL icon
461
Global Net Lease
GNL
$1.94B
$28.1K ﹤0.01%
3,006
-289
-9% -$2.72K
VIR icon
462
Vir Biotechnology
VIR
$1.59B
$27.9K ﹤0.01%
3,111
+377
+14% +$3K
ORIC icon
463
Oric Pharmaceuticals
ORIC
$1.12B
$27.6K ﹤0.01%
2,176
+263
+14% +$2.99K
ETR icon
464
Entergy
ETR
$52.4B
$27.5K ﹤0.01%
+245
New +$24.6K
TSHA icon
465
Taysha Gene Therapies
TSHA
$1.63B
$27.4K ﹤0.01%
6,128
+745
+14% +$3.46K
NVCR icon
466
NovoCure
NVCR
$1.85B
$27.3K ﹤0.01%
2,501
+302
+14% +$3.77K
WVE icon
467
Wave Life Sciences
WVE
$1.11B
$27.2K ﹤0.01%
3,754
+469
+14% +$6.11K
RGC icon
468
Regencell Bioscience
RGC
$3B
$27.1K ﹤0.01%
+1,064
New +$30.1K
OLMA icon
469
Olema Pharmaceuticals
OLMA
$1.01B
$26.3K ﹤0.01%
1,767
+221
+14% +$4.92K
LTC
470
LTC Properties
LTC
$2.19B
$25.9K ﹤0.01%
697
-66
-9% -$2.48K
GTY
471
Getty Realty Corp
GTY
$2.21B
$25.9K ﹤0.01%
814
-77
-9% -$2.41K
PAHC icon
472
Phibro Animal Health
PAHC
$1.37B
$25.4K ﹤0.01%
459
+58
+14% +$2.76K
SHO icon
473
Sunstone Hotel Investors
SHO
$2.21B
$24.9K ﹤0.01%
2,758
-232
-8% -$2.13K
SVRA icon
474
Savara
SVRA
$1.2B
$24.8K ﹤0.01%
4,550
+552
+14% +$3.07K
CRVS icon
475
Corvus Pharmaceuticals
CRVS
$1.22B
$24.4K ﹤0.01%
1,667
+201
+14% +$3.21K
17 18
19
20 21

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q1 2026 Portfolio in Review

As of Q1 2026, GF Fund Management held 666 positions worth $5.98B, up 2.3% from $5.85B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

GF Fund Management's Q1 2026 filing shows 23 new, 324 increased, 223 reduced and 42 closed positions. Its largest new stake was Coherent: 98,000 shares worth $23.3M. The largest sale was Sandisk, an estimated $81.3M.

By sector, the portfolio is most concentrated in Technology at 54% of assets, up from 51% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q1 2026 buy was Coherent: 98,000 shares worth $23.3M.
  • GF Fund Management added most to Walmart Inc in Q1 2026, an estimated $142M increase.
  • GF Fund Management's biggest Q1 2026 reduction was Sandisk, cutting an estimated $81.3M.
  • GF Fund Management fully exited AstraZeneca in Q1 2026, selling an estimated $12.4M.
  • GF Fund Management's ten largest holdings make up 42% of its $5.98B portfolio in Q1 2026.
  • GF Fund Management opened 23 new positions and closed 42 in Q1 2026.
  • GF Fund Management's portfolio value rose 2.3% quarter-over-quarter to $5.98B.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.